OOIR: Observatory of International Research

Papers

(The H4-Index of Annals of Hematology is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration	67
Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate	50
Refractory hepatosplenic T-cell lymphoma was successfully treated with salvage allogeneic hematopoietic stem cell transplantation combined with enhanced myeloablative preconditioning	47
Correction to: Hemophagocytic lymphohistiocytosis in HIV-associated lymphoproliferative disorders	46
Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia	46
Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis	46
Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive acute lymphoblastic leukemia	43
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study	41
Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children’s Cancer Group study ALL-2015	37
Sufficient vitamin D is favorable for children with persistent and chronic immune thrombocytopenia	37
The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction	36
Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma	36
Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia	34
CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease	32
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group	31
Detection of circulating tumor DNA in cerebrospinal fluid prior to diagnosis of spinal cord lymphoma by flow cytometric and cytologic analyses	30
Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experienc	29
Analysis of incidence and risk factors of the multidrug resistant gastrointestinal tract infection in children and adolescents undergoing allogeneic and autologous hematopoietic cell transplantation:	27
Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib	24
Outcome of patients with diffuse large B-cell lymphoma and testicular involvement – real world data	23
Safe administration of venetoclax-obinutuzumab in a chronic lymphocytic leukemia patient with Brugada syndrome	22
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience	22
Optimizing hemophagocytic lymphohistiocytosis screening in children: validation of the HLH-Screen score	22